- Home
- WLGS vs MTEM Comparison
WLGS vs MTEM Comparison
Compare WLGS & MTEM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WLGS
- MTEM
- Stock Information
- Founded
- WLGS 1981
- MTEM 2001
- Country
- WLGS Hong Kong
- MTEM United States
- Employees
- WLGS N/A
- MTEM N/A
- Industry
- WLGS Engineering & Construction
- MTEM Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- WLGS Consumer Discretionary
- MTEM Health Care
- Exchange
- WLGS Nasdaq
- MTEM Nasdaq
- Market Cap
- WLGS 22.2M
- MTEM 9.7M
- IPO Year
- WLGS 2023
- MTEM N/A
- Fundamental
- Price
- WLGS $2.58
- MTEM $0.71
- Analyst Decision
- WLGS
- MTEM
- Analyst Count
- WLGS 0
- MTEM 0
- Target Price
- WLGS N/A
- MTEM N/A
- AVG Volume (30 Days)
- WLGS 269.6K
- MTEM 13.4M
- Earning Date
- WLGS 11-14-2024
- MTEM 11-11-2024
- Dividend Yield
- WLGS N/A
- MTEM N/A
- EPS Growth
- WLGS N/A
- MTEM N/A
- EPS
- WLGS N/A
- MTEM N/A
- Revenue
- WLGS $6,825,879.00
- MTEM $25,470,000.00
- Revenue This Year
- WLGS N/A
- MTEM N/A
- Revenue Next Year
- WLGS N/A
- MTEM N/A
- P/E Ratio
- WLGS N/A
- MTEM N/A
- Revenue Growth
- WLGS 63.69
- MTEM N/A
- 52 Week Low
- WLGS $0.40
- MTEM $0.30
- 52 Week High
- WLGS $4.20
- MTEM $6.48
- Technical
- Relative Strength Index (RSI)
- WLGS 58.66
- MTEM 38.68
- Support Level
- WLGS $2.33
- MTEM $0.31
- Resistance Level
- WLGS $4.20
- MTEM $1.34
- Average True Range (ATR)
- WLGS 0.65
- MTEM 0.14
- MACD
- WLGS 0.04
- MTEM -0.05
- Stochastic Oscillator
- WLGS 34.29
- MTEM 34.48
About WLGS Wang & Lee Group Inc.
WANG & LEE Group Inc operates as an investment holding company. The firm conducts its primary operations through its indirectly wholly owned subsidiary WANG and LEE CONTRACTING LIMITED (WLHK). WLHK provides contract engineering, installation, and out-fitting of the following products and services: low voltage (220v/phase 1 or 380v/phase 3) electrical systems, mechanical ventilation and air-conditioning systems (MVAC), fire safety systems, and water supply and sewage disposal systems.
About MTEM Molecular Templates Inc.
Molecular Templates Inc is a clinical-stage biopharmaceutical company focused on developing therapeutic agents that selectively target tumor cells for the treatment of individuals living with cancer. Its pipeline products are MT-6402, MT-8421 and MT-0169.